Company Overview of CPEX Pharmaceuticals, Inc.
CPEX Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development, licensing, and commercialization of pharmaceutical products utilizing its drug delivery platform technology. The company offers Testim, a gel for testosterone replacement therapy; Ser-120, a product candidate for the treatment of nocturia; and CPE-215, a drug delivery technology, which is used to enhance the absorption of drugs through the nasal mucosa, skin, and eye. The company sells its CPE-215 product to pharmaceutical and biotechnology companies. CPEX Pharmaceuticals, Inc. was founded in 2007 and is based in Wilmington, Delaware. As of April 5, 2011, CPEX Pharmaceuticals, Inc. was taken private.
2 Holland Way
Exeter, NH 03833
Founded in 2007
Key Executives for CPEX Pharmaceuticals, Inc.
Similar Private Companies By Industry
|Quanterix Corporation||United States|
|West Coast Fermentation Center, Inc.||United States|
|Sagres Discovery, Inc.||United States|
|DNA Plant Technology Corp||United States|
|Stonybrook Technology and Applied Research (STAR), Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact CPEX Pharmaceuticals, Inc., please visit www.cpexpharm.com. Company data is provided by Capital IQ. Please use this form to report any data issues.